Senator Bernie Sanders called for a new strategy Monday to encourage drug companies to develop new HIV and AIDS therapies: give them a cash prize, but not the exclusive marketing rights that make the drugs too expensive for many patients.
By creating this $3 billion yearly prize, Sanders said he hopes to open up the new medicines to generic competition immediately — bringing down the costs and changing the incentives of a system that he says is designed to keep the prices artificially high.
Read Full Article »